These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2413738)

  • 1. Histamine release from human basophils by pepstatin A.
    Marone G; Columbo M; Soppelsa L; Condorelli M
    Agents Actions; 1985 Jul; 16(5):306-9. PubMed ID: 2413738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of basophil histamine release induced by pepstatin A.
    Marone G; Columbo M; Soppelsa L; Condorelli M
    J Immunol; 1984 Sep; 133(3):1542-6. PubMed ID: 6205086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transduction events in human basophils. A comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine.
    Warner JA; MacGlashan DW
    J Immunol; 1990 Sep; 145(6):1897-905. PubMed ID: 1697313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of histamine release by formyl methionine-containing peptides.
    Siraganian RP; Hook WA
    J Immunol; 1977 Dec; 119(6):2078-83. PubMed ID: 72118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of histamine release from human basophils in vitro by physiological concentrations of zinc.
    Marone G; Findlay SR; Lichtenstein LM
    J Pharmacol Exp Ther; 1981 May; 217(2):292-8. PubMed ID: 6164779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine and sulfidoleukotriene release from human basophils: different effects of antigen, anti-IgE, C5a, f-Met-Leu-Phe and the novel neutrophil-activating peptide NAF.
    Dahinden CA; Kurimoto J; Baggiolini M; Dewald B; Walz A
    Int Arch Allergy Appl Immunol; 1989; 90(2):113-8. PubMed ID: 2479603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
    de Paulis A; Ciccarelli A; de Crescenzo G; Cirillo R; Patella V; Marone G
    J Allergy Clin Immunol; 1996 Jul; 98(1):152-64. PubMed ID: 8765829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of cAMP-elevating drugs on stimulus-induced cytosolic calcium changes in human basophils.
    Botana LM; MacGlashan DW
    J Leukoc Biol; 1994 Jun; 55(6):798-804. PubMed ID: 7515096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli.
    Warner JA; Peters SP; Lichtenstein LM; Hubbard W; Yancey KB; Stevenson HC; Miller PJ; MacGlashan DW
    J Leukoc Biol; 1989 Jun; 45(6):558-71. PubMed ID: 2470847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils.
    Borrelli I; Loffredo S; Staiano RI; Frattini A; Marone G; Triggiani M
    Int J Immunopathol Pharmacol; 2010; 23(3):737-44. PubMed ID: 20943043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of pepstatin A on neutrophils; cross-deactivation with FMLP].
    Muniain MA; Pozuelo F; Pérez-Venegas JJ; Romero-Tabares A; Rodríguez-Hornillo MC; Garrido M
    Rev Esp Fisiol; 1985 Mar; 41(1):125-31. PubMed ID: 2988085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of human basophils by bacterial products.
    Marone G; Columbo M; Tamburini M; Romagnani S
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):213-5. PubMed ID: 2409018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis.
    Marone G; Giugliano R; Lembo G; Ayala F
    J Invest Dermatol; 1986 Jul; 87(1):19-23. PubMed ID: 2425005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine release from human basophils induced by platelet activating factor: the role of extracellular calcium, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Columbo M; Horowitz EM; Kagey-Sobotka A; Lichtenstein LM
    J Allergy Clin Immunol; 1995 Feb; 95(2):565-73. PubMed ID: 7531728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human basophil releasability. III. Genetic control of human basophil releasability.
    Marone G; Poto S; Celestino D; Bonini S
    J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of mediator release from human basophils induced by platelet-activating factor.
    Columbo M; Casolaro V; Warner JA; MacGlashan DW; Kagey-Sobotka A; Lichtenstein LM
    J Immunol; 1990 Dec; 145(11):3855-61. PubMed ID: 1700998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deuterium-oxide-induced histamine release from basophils of allergic subjects. I. Responsiveness to deuterium oxide requires an activation step.
    Kazimierczak W; Plaut M; Knauer KA; Meier HL; Lichtenstein LM
    Am Rev Respir Dis; 1984 Apr; 129(4):592-6. PubMed ID: 6201094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in filament actin accompanying IgE-dependent and -independent histamine release from IL-3-dependent cultured human basophils.
    Ebisawa M; Saito H; Reason DC; Sakaguchi N; Katsunuma T; Iikura Y
    Int Arch Allergy Appl Immunol; 1991; 94(1-4):71-3. PubMed ID: 1718902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways.
    Knol EF; Koenderman L; Mul FP; Verhoeven AJ; Roos D
    Eur J Immunol; 1991 Apr; 21(4):881-5. PubMed ID: 1708341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basophil "releasability" in patients with asthma.
    Findlay SR; Lichtenstein LM
    Am Rev Respir Dis; 1980 Jul; 122(1):53-9. PubMed ID: 6157344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.